MétaCan
Menu
← Back to cohort

366 Safety and Efficacy of Cryoablation Balloon for the Treatment of Barrett’s Associated Neoplasia: A Meta-Analysis

2019· article· en· W2980300018 on OpenAlexaboutno aff
Donevan Westerveld, Khaai Nguyen, Debdeep Banerjee, Chelsea Jacobs, Nikhil Kadle, Peter V. Draganov, Dennis Yang

Bibliographic record

VenueThe American Journal of Gastroenterology · 2019
Typearticle
Languageen
FieldMedicine
TopicEsophageal Cancer Research and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCryoablationCryotherapyBarrett's esophagusIntestinal metaplasiaDysplasiaCryosurgeryAblationAdverse effectGeneral surgerySurgeryAdenocarcinomaInternal medicineCancer

Abstract

fetched live from OpenAlex

INTRODUCTION: The Cryoballoon Focal Ablation System (CbFAS) (CryoBalloon; Pentax Medical, Redwood City, California, USA), a novel device that permits the conversion of liquid nitrous oxide into its gaseous form within a contact balloon system, was recently introduced for the endoscopic ablation of Barrett’s esophagus (BE) associated neoplasia. We performed a meta-analysis to assess the feasibility, efficacy, and safety of the CbFAS for the treatment of BE neoplasia. METHODS: Several databases were searched for relevant articles (PubMed, Web of Science, Google Scholar, EMBASE) as well as abstracts of recent gastroenterology meetings. Studies included at least 5 patients with BE treated with cryotherapy via cryoballoon device and data extraction, which was performed by two investigators using standardized forms, included age, gender, length of BE segment, treatments prior to CbFAS, procedural time and number ablation sessions, technical feasibility, adverse events, and eradication rates of intestinal metaplasia (CE-IM) and dysplasia (CE-D) at follow-up. Quality of the studies was performed using a modified Newcastle Ottawa Scale. Random effects model was used in the presence of heterogeneity. RESULTS: Seven studies (4 full-length publications, 3 abstracts) met inclusion criteria for a total of 548 ablation sessions in 272 patients. In aggregate, the most common histopathology reported prior to cryoballoon ablation was high-grade dysplasia (n = 131), followed by low-grade dysplasia (n = 75), and intramucosal adenocarcinoma (n = 52). The pooled rate for technical feasibility, defined as completion of cryoablation as intended was 95.8% (95% CI: 93.6-97.5%; I 2 = 13.2%; P = 0.3) (Figure 1a). The pooled rates of CE-IM and CE-D were 85.8% (95% CI: 77.8-92.2%, I 2 = 55.5%; P = 0.04) and 93.8% (95% CI: 85.5-98.7%, I 2 = 74.2%; P = 0.001) (Figure 1b,c), respectively. Funnel plots did not show substantial publication bias (Figure 2). The overall adverse event rate was 12.5% (34 out of 272 patients), of which stricture formation was the most common (5.8%), followed by mucosal laceration (0.7%), perforation (0.4%), and bleeding (0.4%). All adverse events were successfully managed endoscopically. CONCLUSION: This meta-analysis suggests that CbFAS has a comparable safety profile to radiofrequency ablation with a 12.5% adverse event rate. Furthermore, this study demonstrated that CbFAS is associated with high rates of CE-IM (88%) and CE-D (94%). Future prospective comparative trials are needed to corroborate these initial findings.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.025
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.015
Threshold uncertainty score0.079

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.025
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0150.054
Bibliometrics0.0040.005
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.316
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicEsophageal Cancer Research and Treatment→French-language works237,207→